Sana Biotechnology (SANA) Assets Average (2021 - 2026)

Sana Biotechnology (SANA) has 6 years of Assets Average data on file, last reported at $395.2 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 16.48% year-over-year to $395.2 million; the trailing twelve-month figure through Mar 2026 stood at $395.2 million (down 16.48% YoY), and the FY2025 full-year result was $459.0 million, down 13.92% from the prior year.
• Assets Average eased to $395.2 million in Q1 2026, from $426.2 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $1.1 billion in Q1 2022 to a low of $395.2 million in Q1 2026.
• A 5-year average of $656.6 million and a median of $623.3 million in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average climbed 6.99% in 2022 and plunged 37.92% in 2025, its largest moves.
• Tracing SANA's Assets Average over 5 years: stood at $860.4 million in 2022, then tumbled by 30.46% to $598.4 million in 2023, then fell by 11.39% to $530.2 million in 2024, then slipped by 19.62% to $426.2 million in 2025, then dropped by 7.26% to $395.2 million in 2026.
• Business Quant data shows SANA's Assets Average at $395.2 million in Q1 2026, $426.2 million in Q4 2025, and $398.5 million in Q3 2025.